MEDILINK THERAPEUTICS
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.
MEDILINK THERAPEUTICS
Industry:
Biotechnology Genetics Therapeutics
Founded:
2020-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Status:
Active
Total Funding:
120 M USD
Similar Organizations
Laekna Therapeutics
Laekna Therapeutics is a biotech company focusing on drug discovery and development.
Current Employees Featured
Founder
Investors List
Loyal Valley Capital
Loyal Valley Capital investment in Series B - Medilink Therapeutics
Legend Capital
Legend Capital investment in Series B - Medilink Therapeutics
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Medilink Therapeutics
LYFE Capital
LYFE Capital investment in Series B - Medilink Therapeutics
Highlight Capital
Highlight Capital investment in Series B - Medilink Therapeutics
Loyal Valley Capital
Loyal Valley Capital investment in Series A - Medilink Therapeutics
Apricot Capital
Apricot Capital investment in Series A - Medilink Therapeutics
Qiming Venture Partners
Qiming Venture Partners investment in Series A - Medilink Therapeutics